Cargando…
Risk of second breast cancers after lobular carcinoma in situ according to hormone receptor status
BACKGROUND: Although subsequent breast cancer risk after primary lobular carcinoma in situ (LCIS) has been studied intensively, whether the risk of second breast cancer after first LCIS varies with hormone receptor (HR) status of primary tumor remains unclear. METHODS: We identified 10,304 women wit...
Autores principales: | Mao, Kai, Yang, Yaping, Wu, Wei, Liang, Shi, Deng, Heran, Liu, Jieqiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5415001/ https://www.ncbi.nlm.nih.gov/pubmed/28467490 http://dx.doi.org/10.1371/journal.pone.0176417 |
Ejemplares similares
-
Comparison of the Imaging Features of Lobular Carcinoma In Situ and Invasive Lobular Carcinoma of the Breast
Publicado: (2021) -
Impact of Breast Cancer Subtype Defined by Immunohistochemistry Hormone Receptor and HER2 Status on the Incidence of Immediate Postmastectomy Reconstruction
por: Wu, Wei, et al.
Publicado: (2016) -
Risk of contralateral second primary breast cancer according to hormone receptor status in Germany
por: Rusner, Carsten, et al.
Publicado: (2014) -
Genetic analysis of lobular carcinoma in situ and associated invasive lobular cancer
por: Yates, LR, et al.
Publicado: (2010) -
Granulomatous lobular mastitis associated with ductal carcinoma in situ of the breast
por: Oddó, David, et al.
Publicado: (2019)